glp-1 drugs insurance coverage CMS Issues Guidance on Anti-Obesity 1 in 8 adults taking
Description
doi: 10.1111/j.1460-9568.1995.tb00650.x
The best letters connect your obesity to specific health outcomes, reference clinical guidelines supporting GLP-1 use, and explain why alternative treatments have been insufficient
However, extensive human clinical trial data spanning over a decade has not demonstrated increased thyroid cancer risk in people taking these medications
And for patients with obesity, these medications can be lifesaving
The results showed a mainly neutral-to-positive view of these medications
doi: 10.1111/dom.13266
